1.Investigation of an adhesion of both morphine granules (MS-twicelon, Kadian, Pacif) and morphine fine granules (Morphesfine granules) to syringe and catheter tube in administration through a nasogastric tube
Shinya Takada ; Hisae Eguchi ; Norio Kato ; Keishiro Izumi
Palliative Care Research 2008;3(2):101-107
Purpose: Morphine is often administrated through a nosogastric catheter in palliative medicine. As adhesion to the catheter and its stoppage is problematic, adhesion of morphine granules in a nosogastric-tube was investigated. Methods: We investigated it in three following conditions. (1)four morphine products, which were three morphine granules (Pacif®, MS-twicelon® and Kadian®) and a morphine fine granule (Morphes®). (2)four different suspensions of composition, which were water, milk, enteral nutrition liquid and jellied suspension liquid. (3)two sizes of nosogastric catheter (10.5Fr and 13.5Fr). Each morphine product at a dose of 30mg was diluted by each suspension of 20mL in a cup, and injected into each size of nosogastric catheters using a syringe. And the catheter was flushed by the same suspension of 20mL. We counted the granule that adhered to the cup, the syringe and the catheter. Results: As for Pacif® and MS-twicelon®, jellied suspension liquid significantly decreased the number of morphine granules adhered than any of the other suspensions (One-Way Factorial ANOVA and Scheffe's F test: p<0.05) in both sizes of catheters. Only jellied suspension liquid made Kadian® pass the both catheters, but they were obstructed by Kadian® diluted in the other suspensions. Morphes® diluted in water had a tendency to adhere compared to those in milk, enteral nutrition liquid or jellied suspension liquid. Additionally, using the jellied suspension liquid, the maximum dosing of Pacif®, MS-twicelon® and Kadian® were 240mg, 90mg and 60mg, respectively. Conclusion: When administering morphine granules through a nasogastric-tube, using jellied suspension liquid is recommended. Palliat Care Res 2008; 3(2): 101-107
2.An Examination of Stroke Patients Undergoing Rehabilitation in a Convalescent Rehabilitation Ward While Receiving Dialysis Treatment
Joji KATO ; Yasuhiro SHIMIZU ; Kenichi OZAKI ; Takahiro SHIMODAIRA ; Osamu HARA ; Izumi KONDO
The Japanese Journal of Rehabilitation Medicine 2013;50(9):751-756
Dialysis treatment was first introduced in the convalescent rehabilitation ward after the medical fee revision in April 2012 in Japan. In this study, we examined 4 stroke patients who underwent rehabilitation in the convalescent rehabilitation ward while receiving dialysis. We collected information on the patients' age, sex, disease, dialysis period, duration of hospitalization during the acute and recovery phases, the number of units of exercise, discharge destination after hospital, complications, and their Functional Independence Measure (FIM) scores. The average age of the subjects( 2 men and 2 women) was 71.0±9.5 years. Two of the 4 patients had cerebral hemorrhage and the other 2 had cerebral infarction. The dialysis period was 16.8±21.7 months. The duration of hospitalization during the acute phase was 50.0±20.3 days, while that in the convalescent rehabilitation ward was 120.0±28.2 days. The average exercise amount per day was 6.01±1.17 units in the convalescent rehabilitation ward. The total FIM score was 59.3±19.2 at admission and 94.5±27.0 at discharge. The FIM efficiency was 0.29±0.16. In all cases, the discharge destination was home. Three of the subjects showed progression of their renal anemia. One subject developed shunt vessel stenosis and one developed delirium as complications. We conclude that rehabilitation in the convalescent rehabilitation ward for dialysis is beneficial to patients due to the increased amount of exercise that they receive. In addition, such rehabilitation enables the patients to return home in good health, similar to the case of non-dialysis patients.
3.Development and introduction of a regional cooperation clinical pathway for home palliative care
Koichiro Kobayashi ; Mayumi Murakami ; Tohru Tomiyama ; Nobuki Itakura ; Mariko Kato ; Izumi Nakaya ; Miwako Takeda ; Yuko Yokoyama ; Noriko Hirai ; Hiroyasu Kawakami
Palliative Care Research 2013;8(2):326-333
In order to promote regional cooperation in palliative care, we developed a regional cooperation clinical pathway for home palliative care that offers simple support and is easy to use. We then administered a questionnaire survey to 14 healthcare professionals with various specialties who were involved in the introduction of the pathway, and we revised the pathway on the basis of the survey results. The revised pathway was then tested in 13 patients who were discharged from 3 designated cancer care hospitals in Toyama City to home care, and another questionnaire survey was conducted afterwards in the same manner. The mean overall score on the questionnaire was 2 in seven, 3 in seven (on a scale of 0 to 3) at the time of introduction, whereas the score after trial use was 1 in one, 2 in four, 3 in five. We believe that more innovative approaches to the implementation of such pathways are required.
4.Support system probability using IT cloud for a palliative care team to support a home palliative care
Koichiro Kobayashi ; Mayumi Murakami ; Toru Tomiyama ; Mariko Kato ; Izumi Nakaya ; Miwako Takeda ; Yuko Yokoyama ; Noriko Hirai ; Hiroyasu Kawakami
Palliative Care Research 2013;8(2):371-375
Purpose and Methods: Aiming at the relief of suffering by the palliative care team and prompt information sharing between healthcare professionals with various specialties, We introduced new IT cloud system, carried out questionnaire survey and examined the usefulness to 11 persons of healthcare professionals. Five cases where the palliative care team was concerned during the hospitalize became a home palliative care to the tried half a year. Results: All the members were using the personal computer as an input device. Four persons were using the iPhone. Two persons had the experience inputted on the spot. Nine persons of the input time were 5 or less minutes. All the members were perusing at various places by various device. Urgently and vital mail was useful: 3 in six, 2 in three, 1 in one, 0 in one. Information content were suitable: 3 in nine, 2 in two. Cooperation were completed in the smooth: 3 in nine, 2 in two. Have you utilized EIR for the home palliative care?: 3 in nine, 2 in two. Conclution: To the support of information sharing and palliative care team by IT cloud system transduction, the useful probability was suggested in the home palliative care.
5.The Present Situation Regarding Kampo Medicine Use and Kampo Education in Three Hokkaido Hospitals
Izumi SATO ; Keiko MAMIYA ; Yasuhito Kato ; Satoshi SHIMANO ; Koichi OTAKI ; Toshio AWAYA ; Yoshikazu TASAKI ; Takayuki KUNISAWA ; Hiroshi IWASAKI
Kampo Medicine 2017;68(2):157-164
Medical therapies, adapted to local requirements, are necessary in the field of community medicine. Generalized medical treatment is often all there is in Japan's Konsen Area, due to the large number of elderly people and a paucity of medical institutions. Kampo medical treatment is useful for elderly patients with plural diseases, and the demand for such treatment has been increasing. Therefore, we collected data on Kampo prescriptions prescribed by the doctors at the Nakashibetsu Municipal Hospital, which is the main local hospital in the Konsen Area, from 2010 to 2013. We conducted similar investigations at the Kushiro Red Cross Hospital in Kushiro city, which is centrally located in the Konsen Area, and at Asahikawa Medical University Hospital in Asahikawa, central Hokkaido. The aim of these investigations was to compare Kampo medicine use based on hospital location and size. The results can be used in community medicine to enhance the use of Kampo medicine with increase for its demand. Medical students and doctors should be educated in Kampo medicines, since their prescriptions have a significant impact on community health.
6.A pediatric case of anaphylactic shock induced by tipepidine hibenzate (Asverin)
Hirotake TAKAI ; Izumi KATO ; Kanako MITSUNAGA ; Mayumi HARA ; Takahiro KODAMA ; Masaki KANAZAWA ; Masaru TERAI
Asia Pacific Allergy 2018;8(4):e37-
Tipepidine hibenzate (Asverin) is commonly used as an antitussive drug for acute and chronic cough in various age groups and is generally safe and well-tolerated. However, we experienced a case of tipepidine hibenzate-induced anaphylactic shock in a 1-year-old boy. After ingesting cold medication including tipepidine hibenzate, the patient presented with generalized erythema and urticaria, swollen face, coughing, wheezing and vomiting, together with hypotension and a decreased level of consciousness. To identify the culprit drug, we performed skin prick tests (SPTs) and oral drug provocation tests (DPTs). SPTs revealed a negative reaction for all drugs, but DPTs caused a positive reaction only for a full therapeutic dose of tipepidine hibenzate. Physicians need to consider tipepidine hibezate as a culprit drug when anaphylaxis occurs after taking anticough or common cold medication.
Anaphylaxis
;
Child
;
Common Cold
;
Consciousness
;
Cough
;
Drug Hypersensitivity
;
Erythema
;
Humans
;
Hypotension
;
Male
;
Respiratory Sounds
;
Skin
;
Urticaria
;
Vomiting
7.Low-Dose Pegylated Interferon α-2b Plus Ribavirin for Elderly and/or Cirrhotic Patients with Genotype 2 Hepatitis C Virus.
Hideyuki TAMAI ; Naoki SHINGAKI ; Yoshiyuki MORI ; Kosaku MORIBATA ; Akira KAWASHIMA ; Yoshimasa MAEDA ; Toru NIWA ; Hisanobu DEGUCHI ; Izumi INOUE ; Takao MAEKITA ; Mikitaka IGUCHI ; Jun KATO ; Masao ICHINOSE
Gut and Liver 2016;10(4):617-623
BACKGROUND/AIMS: This study aimed to predict sustained viral response (SVR) to low-dose pegylated interferon (PEG-IFN) plus ribavirin of elderly and/or cirrhotic patients with genotype 2 hepatitis C virus (HCV) using viral response within 2 weeks. METHODS: Low-dose PEG-IFN-α-2b plus ribavirin was administered to 50 elderly and/or cirrhotic patients with genotype 2 HCV for 24 weeks. The dynamics of HCV RNA and HCV core antigen levels within 2 weeks were measured. RESULTS: The patients' median age was 66 years. There were 21 male and 29 female patients. The median baseline HCV RNA level was 5.7 log IU/mL. Rapid viral response was achieved in 17 patients (34%), SVR in 28 (56%), and two (4%) discontinued treatment. Univariate analysis of factors contributing to SVR showed significant differences for sex, baseline virus level, and response within 4 weeks. When 40 fmol/L was set as the cutoff value for the core antigen level at 1 week, the sensitivity, specificity, positive predictive value, negative predictive value, and accuracy for predicting SVR were 93%, 75%, 84%, 88%, and 85%, respectively. CONCLUSIONS: Low-dose PEG-IFN plus ribavirin was a safe and cost-effective treatment for elderly and/or cirrhotic patients with genotype 2 HCV, and the viral response within 2 weeks was a useful predictor of SVR.
Aged*
;
Female
;
Genotype*
;
Hepacivirus*
;
Hepatitis C*
;
Hepatitis*
;
Humans
;
Interferons*
;
Liver Cirrhosis
;
Male
;
Ribavirin*
;
RNA
;
Sensitivity and Specificity
8.Prediction of a Null Response to Pegylated Interferon alpha-2b Plus Ribavirin in Patients with High Viral Load Genotype 1b Hepatitis C.
Yuki WADA ; Hideyuki TAMAI ; Akira KAWASHIMA ; Naoki SHINGAKI ; Yoshiyuki MORI ; Masanori KAWAGUCHI ; Kosaku MORIBATA ; Hisanobu DEGUCHI ; Kazuki UEDA ; Izumi INOUE ; Takao MAEKITA ; Mikitaka IGUCHI ; Jun KATO ; Masao ICHINOSE
Gut and Liver 2014;8(4):421-427
BACKGROUND/AIMS: The present study aimed to clarify whether virological response within 2 weeks after therapy initiation can predict a null response to pegylated interferon alpha-2b plus ribavirin therapy in patients with high viral load genotype 1b hepatitis C. METHODS: The participants consisted of 72 patients with high viral load genotype 1b. The dynamics of viral load within 2 weeks were measured. RESULTS: Significant differences between null responders and nonnull responders were noted for interleukin (IL)-28B genotype, amino acid 70 substitution, alpha-fetoprotein, low-density lipoprotein cholesterol, hyaluronic acid, and viral response. The area under the curve (AUC) for the receiver operating characteristic curve of the hepatitis C virus (HCV) RNA level decline at 2 weeks (AUC=0.993) was the highest among the factors predicting the null response. When the cutoff value for the HCV RNA level decline at 2 weeks was set at 0.80 log, the sensitivity, specificity, positive predictive value, negative predictive value, and accuracy in predicting a null response were 82%, 96%, 82%, 96%, and 94%, respectively. In comparison, values for the non-TT and mutant type of amino acid 70 substitution were similar to those for HCV RNA level decline at 2 weeks. CONCLUSIONS: Virological response at 2 weeks or the combination of IL-28B and amino acid 70 substitution are accurate predictors of a null response.
Administration, Oral
;
Adult
;
Aged
;
Antiviral Agents/*administration & dosage
;
Area Under Curve
;
Drug Therapy, Combination
;
Female
;
Genotype
;
Hepatitis C, Chronic/*drug therapy/genetics
;
Humans
;
Injections, Subcutaneous
;
Interferon-alpha/*administration & dosage
;
Male
;
Medication Adherence
;
Polyethylene Glycols/*administration & dosage
;
Prospective Studies
;
RNA, Viral/metabolism
;
Recombinant Proteins/administration & dosage
;
Ribavirin/*administration & dosage
;
Treatment Outcome
;
Viral Load
;
Young Adult
9.Respiratory Troubles and Diseases caused by Farm Work
Kiyoichi Noda ; Yukio Konishi ; Jiro Kanno ; Shojiro Izumi ; Kiichi Kaishio ; Kohei Kameyama ; Masanaga Takato ; Koji Isomura ; Yuzuru Kanbe ; Eisuke Kato ; Isamu Ebihara ; Akio Uchida ; Atsushi Ueda ; Shigeru Nomura ; Akimasa Miyamoto
Journal of the Japanese Association of Rural Medicine 1978;26(5):693-713
It is to be noted that in rural districts where they live and work in fresh and clean air the incidence of chronic obstructive pulmonary diseases is as high as in the districts of air-pollution. Besides, there are a variety of respiratory diseases particularly incidental to life-environment and farm work. To be more informed of their actual conditions, the Japanese Association of Rural Medicine organized a special study group and has carried out various studies for four consecutive years with grants from the Ministry of Health and Welfare. The major results obtained are as follows
(1) There were a variety of farm operations which produced or increased respiratory symptoms, including thrashing and scattering of agricultural chemicals;
(2) It became clear that there existed in an advanced age group certain cases of “agricultural pneumoconiosis” which could be regarded as the terminal of the so-called “thrash-bronchitis”
(3) Among the cultivators of rush, raw material for Tatami, There existed cases of pneumoconiosis;
(4) There were a variety of agents to produce bronchial asthma, such as rice straw, chaff, tea-leaves and chrysanthemum-leaves;
(5) In Japan only two cases of farmer's lung were reported prior to this study. One more case was added to the list by this study group. Besides, cases positive to fungous agents were found among farmers in considerably high percentage.
10.Cross-Sectional and Longitudinal Associations between Forearm Bone Mineral Density and Anthropometry in Adult Japanese Men and Women
Masahiro ISHIZAWA ; Kazuya FUJIHARA ; Junko YACHIDA ; Izumi IKEDA ; Takaaki SATO ; Takaho YAMADA ; Ayako KOBAYASHI ; Shiro TANAKA ; Yoshimi NAKAGAWA ; Takashi MATSUZAKA ; Hitoshi SHIMANO ; Minoru TASHIRO ; Satoru KODAMA ; Kiminori KATO ; Hirohito SONE
Journal of Bone Metabolism 2024;31(1):21-30
Background:
No consensus exists regarding which anthropometric measurements are related to bone mineral density (BMD), and this relationship may vary according to sex and age. A large Japanese cohort was analyzed to provide an understanding of the relationship between BMD and anthropometry while adjusting for known confounding factors.
Methods:
Our cohort included 10,827 participants who underwent multiple medical checkups including distal forearm BMD scans. Participants were stratified into four groups according to age (≥50 years or <50 years) and sex. The BMD values were adjusted for confounding factors, after which single and partial correlation analyses were performed. The prevalence of osteopenia was plotted for each weight index (weight or body mass index [BMI]) class.
Results:
Cross-sectional studies revealed that weight was more favorably correlated than BMI in the older group (R=0.278 and 0.212 in men and R=0.304 and 0.220 in women, respectively), whereas weight and BMI were weakly correlated in the younger age groups. The prevalence of osteopenia exhibited a negative linear relationship with weight among older women ≥50 years of age, and an accelerated increase was observed with decreasing weight in older men weighing <50 kg and younger women weighing <60 kg. When weight was replaced with BMI, the prevalence was low in most subgroups classified by weight.
Conclusions
Weight, rather than BMI, was the most important indicator of osteopenia but it might not be predictive of future bone loss.